Similarly, OVCAR4 human ovarian serous adenocarcinoma cells were sensitized to carboplatin by treatment with 102-5 anti-CLPTM1L (Supplementary Fig. 4a). The gene discussed is CLPTM1L; the disease is ovarian serous adenocarcinoma.